>

PAREXEL Stock Profile

<div class='circular--portrait' style='background:#000000;color: white;font-size:3em;padding-top: 40px;;'>PRX</div>
Analyze Filter   Check how we calculate scores
Equity ratings for PAREXEL International Corp are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 28, 2019 and ending today February 26, 2020. Click here to learn more.
PAREXEL International Corp cannot be verified against its exchange. Apparently, PAREXEL International is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

PAREXEL International Profile

PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide.. The public information regarding PAREXEL International Corp's current market price is not available at this time.
Legal NamePAREXEL International Corp
CEOEllen ZaneView All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering PAREXEL International
Piotroski F Score
Academic score to determine the current strength of PAREXEL International financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
PAREXEL International ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Profitability
Few selected profitability drivers of PAREXEL International representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
PAREXEL International Corp (PRXL) is traded on NASDAQ in USA and employs 18,600 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 4.5 B. PAREXEL International conducts business under null sector and is part of null industry. The entity has 51.12 M outstanding shares of which 506.64 K shares are at this time shorted by private and institutional investors with about 0.57 trading days to cover. PAREXEL INTL CP currently holds about 302.7 M in cash with 306.4 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.92.
Check PAREXEL International Probability Of Bankruptcy

PAREXEL Stock Top Holders

PAREXEL Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Ramsey Quantitative SystemsCommon Shares14.4 K240 K
Blackrock IncCommon Shares5.4 M474.1 M
View PAREXEL International Diagnostics

PAREXEL Stock Against Markets

PAREXEL International Corp cannot be verified against its exchange. Apparently, PAREXEL International is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

PBProsperity BancsharesStock
PGProcter Gamble CompanyStock
PXPraxairStock
DTILPrecision BioSciencesStock
PFODFPremier FoodsOTC Stock